Announcing the 2023 St. Baldrick’s Fellows
The hope for better futures for kids with cancer relies on childhood cancer research. And that research relies — not only today but for decades to come — on the training of the next generation of childhood cancer researchers. This new investment of over $1.2 million puts these young researchers on that path to finding new cures.
Read more below about what this new investment is supporting.
Meet 2023 Ambassador Martha: A Legacy of Courage, Compassion, and Conviction
For seven years, #TeamMartha was the rallying cry of a devoted community — family, friends, teammates, caregivers and even those who learned of her story from afar — who supported Martha Riedel in her battle with cancer. It symbolizes a life lived with courage, determination, and relentless zeal for all that she loved. It’s who Martha was.
“Fierce Face” Martha
Meet the 2023 St. Baldrick’s Ambassadors!
St. Baldrick’s Ambassadors represent the wide diversity of kids diagnosed with childhood cancers. Their stories highlight the importance of supporting the best childhood cancer research so all kids diagnosed can live long, healthy, productive and happy lives.
Research Outcomes: Your Dollars at Work
Read on to learn about some of the research that – thanks to you – is changing the world of childhood cancer care.
Meet the RED Sparkle Octopus Crusaders & Their Inspiration
by David Gosser, team captain and dad
The RED Sparkle Octopus Crusaders (RSOC) Team honors four children – Nina, Tommy, Amaya, and Kristina – who met in 2005, while in treatment at the Children’s Hospital of the King’s Daughters (CHKD) in Norfolk, Virginia. They started shaving individually in 2005/06 and formed the original team in 2009; this version came together in 2014. Other families affected by childhood cancer and dozens of good friends have joined the team’s efforts over the years. Since inception, the RSOC have raised over $380,000 for the St. Baldrick’s Foundation. They remain fully committed to funding research to create cures, united by the hope that they are helping other kids and families find better outcomes. The team’s name is a combined tribute to the memories of the four Angels.
Battle Osteosarcoma Funds $1.35 Million in Research: Honoring Charlotte, Dylan and Tyler
Two years ago, a group of three dedicated moms rallied some dear friends to achieve what seemed like an ambitious goal to support osteosarcoma research. As you’ll see below, they knocked that one out of the park!
Battle Osteosarcoma volunteers set out to raise $150,000, then raised more than $1.3 million!
What Is Sarcoma?
Dr. Jeffrey Toretsky is a St. Baldrick’s researcher at the Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. He explains what sarcoma is, how it’s diagnosed and treated, and how research is helping kids and adults with this type of cancer.
What is sarcoma?
A sarcoma is a bumpy tumor that occurs in the connective tissues (nerves, muscles and bones) anywhere in the body.
Sarcomas are rare, especially in young children. In kids between 10 and 20, sarcomas make up about 20-25% of childhood cancer diagnoses.
Sarcomas can start off being tiny lumps that you can’t feel. They can spread through the body, or metastasize, before they grow big enough to be seen.
Discoveries that Shift Paradigms with Dr. Poul Sorensen
Formerly known as the St. Baldrick’s – Stand Up to Cancer Pediatric Cancer Dream Team, this team is now the St. Baldrick’s EPICC Team (Empowering Pediatric Immunotherapies for Childhood Cancer).
St. Baldrick’s is all about shifting paradigms. When three men decided to shave heads at their industry’s March 17, 2000 St. Patrick’s Day party, they didn’t set out to change the landscape of childhood cancer research funding. But today the St. Baldrick’s Foundation is the largest non-government funder of childhood cancer research grants.
Twenty years later, the paradigm shifts keep coming, and Poul Sorensen, MD, PhD has been a part of several of them. Last month we joined some very special guests on a visit to his lab at the University of British Columbia, where he is a Professor of Pathology and holds the Johal Endowed Chair in Childhood Cancer Research.
Dr. Poul Sorensen (right) with his Co-Principal Investigator, Dr. Mads Daugaard (left).
St. Baldrick’s Researcher Uncovers Promising New Compound That Kills Ewing Sarcoma
What happens when you give a researcher funding and freedom to follow the science?
Breakthroughs.
Just ask the Robert J. Arceci Innovation Award winner Dr. Kimberly Stegmaier. For her, that powerful combination of funding and freedom led to the discovery of a promising combination of molecules that could change the lives of kids with Ewing sarcoma, the second most common bone cancer found in children.
Older Posts »
SBF
Tweets »
